Skip to main content
SpringerLink
Log in

Staphylococcal Infections and Kidney Disease

  • Chapter
  • First Online:
Tropical Nephrology

  • 338 Accesses

Abstract

Staphylococcus aureus is related to the onset of diseases that range from simple infections (cellulitis, folliculitis, impetigo) to severe infections (pneumonia, meningitis, endocarditis, septic shock, septicemia, osteomyelitis, septic arthritis, and others), and it is considered the second most common pathogen involved in bloodstream infections (bacteremia). Important risk factors for severe infections are heart disease, diabetes mellitus, obstructive pulmonary disease, and neoplasms, but the highest risk involves patients on hemodialysis, peritoneal dialysis, HIV patients, and transplant patients. The association between the nephrologist’s daily routine and Staphylococcus occurs in several ways that include practically all activities related to the specialty (chronic renal replacement therapy, acute kidney injury, interventional nephrology, and clinical nephrology). Of the total of S. aureus-associated bacteremia, 15–66% occur in individuals with dialytic chronic kidney disease, and, in dialysis patients, this pathogen accounts for approximately 40% of severe infections. Patients on chronic hemodialysis are colonized by methicillin-resistant Staphylococcus aureus (MRSA) in approximately 3–20% of cases, reaching 65% in some studies. Infections resulting from bacteremia associated with vascular access in hemodialysis patients are endocarditis, osteomyelitis, septic arthritis, and sepsis. Sepsis is the main cause of association with acute kidney injury (AKI) in hospitals and intensive care units. Approximately 50% of AKI patients in the intensive care setting have sepsis. Chronic dialysis patients have a 40-fold higher risk than the general population to develop severe sepsis, as well as a higher risk of death.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wertheim HF, Melles DC, Vos MC, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005;5(12):751–62.

    Article  PubMed  Google Scholar 

  2. Horn J, Stelzner K, Rudel T, Fraunholz M. Insidejob: staphylococcus aureus host pathogen interaction. Int J Med Microbiol. 2017. pii: S1438-4221(17)30316-8.

    Google Scholar 

  3. Laupland KB. Incidence of bloodstream infection: a review of population-based studies. Clin Microbiol Infect. 2013;19(6):492–500.

    Article  CAS  PubMed  Google Scholar 

  4. Timsit JF, Laupland KB. Update on bloodstream infections in ICUs. Curr Opin Crit Care. 2012;18(5):479–86.

    Article  PubMed  Google Scholar 

  5. Shurland S, Zhan M, Bradham DD, Roghmann MC. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol. 2007;28:273–9.

    Article  PubMed  Google Scholar 

  6. Hiramatsu K, Aritaka N, Hanaki H, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet. 1997;350(9092):1670–3.

    Article  CAS  PubMed  Google Scholar 

  7. Siddiqui AH, Whitten RA. Methicillin resistant Staphylococcus aureus (MRSA). StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2018 Feb 22.

    Google Scholar 

  8. Vandecasteele SJ, Boelaert JR, De Vriese AS. Staphylococcus aureus infections in hemodialysis: what a nephrologist should know. Clin J Am Soc Nephrol. 2009;4(8):1388–400.

    Article  PubMed  Google Scholar 

  9. Kallen AJ, Mu Y, Bulens S, et al. Health care-associated invasive MRSA infections, 2005–2008. JAMA. 2010;304:641–8.

    Article  CAS  PubMed  Google Scholar 

  10. Nielsen LH, Jensen-Fangel S, Benfield T, et al. Risk and prognosis of Staphylococcus aureus bacteremia among individuals with and without end-stage renal disease: a Danish, population-based cohort study. BMC Infect Dis. 2015;15:6.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Lessa FC, Mu Y, Ray SM, Dumyati G, et al. Impact of USA300 methicillin-resistant Staphylococcus aureus on clinical outcomes of patients with pneumonia or central line-associated bloodstream infections. Clin Infect Dis. 2012;55(2):232–41.

    Article  PubMed  Google Scholar 

  12. Vanholder R. Central vein hemodialysis catheters and infection: a plea for timely referral and appropriate hygienic measures. Acta Clin Belg. 2003;58(6):342–4.

    Article  CAS  PubMed  Google Scholar 

  13. Lederer SR, Riedelsdorf G, Schiffl H. Nasal carriage of methicillin-resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients. Eur J Med Res. 2007;12(7):284–8.

    CAS  PubMed  Google Scholar 

  14. D’Agata EMC. Addressing the problem of multidrug-resistant organisms in dialysis. Clin J Am Soc Nephrol. 2018;13(4):666–8.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Pop-Vicas A, Strom T, D’Agata EMC. Multidrug-resistant gram-negative bacilli among chronic hemodialysis patients. Clin J Am Soc Nephrol. 2008;3:752–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Centers for Disease Control and Prevention: Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep. 2001;50:1–43.

    Google Scholar 

  17. Grothe C, Taminato M, Belasco A, et al. Prophylactic treatment of chronic renal disease in patients undergoing peritoneal dialysis and colonized by Staphylococcus aureus: a systematic review and meta-analysis. BMC Nephrol. 2016;17(1):115.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Aktaş E, Pazarli O, Külah C, Cömert F, Külah E, Sümbüloğlu V. Determination of Staphylococcus aureus carriage in hemodialysis and peritoneal dialysis patients and evaluation of the clonal relationship between carriage and clinical isolates. Am J Infect Control. 2011;39:421–5.

    Article  PubMed  Google Scholar 

  19. Kellum JA, Prowle JR. Paradigms of acute kidney injury in the intensive care setting. Nat Rev Nephrol. 2018;14(4):217–30.

    Article  PubMed  Google Scholar 

  20. Parmar A, Langenberg C, Wan L, et al. Epidemiology of septic acute kidney injury. Curr Drug Targets. 2009;10(12):1169–78.

    Article  CAS  PubMed  Google Scholar 

  21. Tillmann B, Wunsch H. Epidemiology and outcomes. Crit Care Clin. 2018;34:15–27.

    Article  PubMed  Google Scholar 

  22. Sakhuja A, Nanchal RS, Gupta S, et al. Trends and outcomes of severe sepsis in patients on maintenance dialysis. Am J Nephrol. 2016;43(2):97–103.

    Article  CAS  PubMed  Google Scholar 

  23. Prescott HC, Langa KM, Iwashyna TJ. Readmission diagnoses after hospitalization for severe sepsis and other acute medical conditions. JAMA. 2015;313(10):1055–7. (Prescott HC, Angus DC. Enhancing recovery from sepsis: a review. JAMA. 2018;319(1):62–75.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Bartz RR, Fu P, Suliman HB, et al. Staphylococcus aureus sepsis induces early renal mitochondrial DNA repair and mitochondrial biogenesis in mice. PLoS One. 2014;9(7):e100912.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Gaudry S, Hajage D, Schortgen F, et al. Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med. 2016;375(2):122–33.

    Article  PubMed  Google Scholar 

  26. Fani F, Regolisti G, Delsante M, et al. Recent advances in the pathogenetic mechanisms of sepsis-associated acute kidney injury. J Nephrol. 2018;31(3):351–59.

    Google Scholar 

  27. Luque Y, Mesnard L. Vancomycin nephrotoxicity: frequency and mechanistic aspects. Nephrol Ther. 2018;14(Suppl 1):S133–8.

    Article  PubMed  Google Scholar 

  28. Elbarbry F. Vancomycin dosing and monitoring: critical evaluation of the current practice. Eur Eur J Drug Metab Pharmacokinet. 2018;43(3):259–68.

    Google Scholar 

  29. Kronbichler A, Kerschbaum J, Mayer G. The influence and role of microbial factors in autoimmune kidney diseases: a systematic review. J Immunol Res. 2015;2015:858027.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Koyama A, Kobayashi M, Yamaguchi N, et al. Glomerulonephritis associated with MRSA infection: a possible role of bacterial superantigen. Kidney Int. 1995;47:207–16.

    Article  CAS  PubMed  Google Scholar 

  31. Nasr SH, Fidler ME, Valeri AM, et al. Postinfectious glomerulonephritis in the elderly. J Am Soc Nephrol. 2011;22(1):187–95.

    Article  PubMed  Google Scholar 

  32. Wang SY, Bu R, Zhang Q, et al. Clinical, pathological, and prognostic characteristics of glomerulonephritis related to staphylococcal infection. Medicine (Baltimore). 2016;95(15):e3386.

    Article  CAS  PubMed Central  Google Scholar 

  33. Stegeman CA, Cohen Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CGM. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med. 1994;120(1):12–7.

    Article  CAS  PubMed  Google Scholar 

  34. Popa ER, Stegeman CA, Abdulahad WH, et al. Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener’s granulomatosis. Rheumatology. 2007;46(6):1029–33.

    Article  CAS  PubMed  Google Scholar 

  35. Radhakrishnan J, Cattran DC. The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual patient. Kidney Int. 2012;82(8):840–56.

    Article  PubMed  Google Scholar 

  36. Stegeman CA, Cohen Tervaert JW, de Jong PE, et al. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener’s granulomatosis. N Engl J Med. 1996;335:16–20.

    Article  CAS  PubMed  Google Scholar 

  37. Jung N, Rieg S. Essentials in the management of S. aureus bloodstream infection. Infection Aug. 2018;46(4):441–42.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, State University of Campinas, Campinas, Sao Paulo, Brazil

    Maria Almerinda Vieira Fernandes Ribeiro Alves

Authors
  1. Maria Almerinda Vieira Fernandes Ribeiro Alves
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Fortaleza, Fortaleza, Ceará, Brazil

    Geraldo Bezerra da Silva Junior

  2. Federal University of Ceará, Fortaleza, Ceará, Brazil

    Elizabeth De Francesco Daher

  3. Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil

    Elvino Barros

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Alves, M.A.V.F.R. (2020). Staphylococcal Infections and Kidney Disease. In: Bezerra da Silva Junior, G., De Francesco Daher, E., Barros, E. (eds) Tropical Nephrology. Springer, Cham. https://doi.org/10.1007/978-3-030-44500-3_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-44500-3_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-44499-0

  • Online ISBN: 978-3-030-44500-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation